Dr Mark Rafferty and Dr Matthew Wilson, consultant haematologists at the Beatson West of Scotland Cancer Centre in Glasgow discuss the role of bispecific agents in Diffuse Large B Cell Lymphoma (DLBCL) and comment on the retrospective and prospective data presented at the meeting and discuss how these agents may ft into UK clinical practice in the future.
Only to be shared with relevant UK haematology healthcare professionals.
CPD® Accreditation
To support your continued professional development the resources hosted in the Resources hub have been certified for CPD® accreditation by the CPD® Certification Service.
Please complete the Request CPD® Certificate form to request a CPD® accredited certificate.
